These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25460021)

  • 1. Behavioral studies on anxiety and depression in a drug discovery environment: keys to a successful future.
    Bouwknecht JA
    Eur J Pharmacol; 2015 Apr; 753():158-76. PubMed ID: 25460021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back to the future of psychopharmacology: A perspective on animal models in drug discovery.
    Hendriksen H; Groenink L
    Eur J Pharmacol; 2015 Jul; 759():30-41. PubMed ID: 25814259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
    Brunner D; Balcı F; Ludvig EA
    Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New dimensions in the use of rodent behavioral tests for novel drug discovery and development.
    Hoffman KL
    Expert Opin Drug Discov; 2016; 11(4):343-53. PubMed ID: 26894954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives.
    Bueters T; Ploeger BA; Visser SA
    Drug Discov Today; 2013 Sep; 18(17-18):853-62. PubMed ID: 23665277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of anxiety for drug discovery and brain research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():299-321. PubMed ID: 20012406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.
    Pratt J; Winchester C; Dawson N; Morris B
    Nat Rev Drug Discov; 2012 Jun; 11(7):560-79. PubMed ID: 22722532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethological concepts enhance the translational value of animal models.
    Peters SM; Pothuizen HH; Spruijt BM
    Eur J Pharmacol; 2015 Jul; 759():42-50. PubMed ID: 25823814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the anxiety-depression continuum in chicks.
    Warnick JE; Huang CJ; Acevedo EO; Sufka KJ
    J Psychopharmacol; 2009 Mar; 23(2):143-56. PubMed ID: 18515452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and molecular techniques utilized to investigate animal models of depression. An updated review.
    Ayuob NN; Balgoon MJ
    Microsc Res Tech; 2018 Oct; 81(10):1143-1153. PubMed ID: 30168883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An industry perspective on the role and utility of animal models of pain in drug discovery.
    Whiteside GT; Pomonis JD; Kennedy JD
    Neurosci Lett; 2013 Dec; 557 Pt A():65-72. PubMed ID: 23994390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel anxiolytic agents--the trials and tribulations of pre-clinical models of anxiety.
    Andrews NA; Papakosta M; Barnes NM
    Neurobiol Dis; 2014 Jan; 61():72-8. PubMed ID: 24120978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of depression and anxiety: What do they tell us about human condition?
    Neumann ID; Wegener G; Homberg JR; Cohen H; Slattery DA; Zohar J; Olivier JD; Mathé AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1357-75. PubMed ID: 21129431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of depression and neuroplasticity: assessing drug action in relation to behavior and neurogenesis.
    Xu Y; Barish PA; Pan J; Ogle WO; O'Donnell JM
    Methods Mol Biol; 2012; 829():103-24. PubMed ID: 22231809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of preclinical animal models in pharmaceutical discovery and development: a need to bring in cerebro to the in vivo discussions.
    Everitt JI
    Toxicol Pathol; 2015 Jan; 43(1):70-7. PubMed ID: 25351920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.